These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9818704

  • 1. Crescentic glomerulonephritis developing 3 months after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Takeuchi M, Tamaoki A, Tada A, Jyo Y, Nomura S, Takahashi K, Ohsawa G, Kibata M.
    Bone Marrow Transplant; 1998 Oct; 22(7):725-7. PubMed ID: 9818704
    [Abstract] [Full Text] [Related]

  • 2. [A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group].
    Chou T, Ishiguro T, Imajo K, Kawano F, Gondo H, Kasai M, Masuda M, Koike M, Shimazaki C, Hara M, Shinagawa K, Ogawa M, Takaku F, Harada M.
    Rinsho Ketsueki; 1999 Oct; 40(10):1058-67. PubMed ID: 10565222
    [Abstract] [Full Text] [Related]

  • 3. [High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study].
    Kitajima H, Nasu K, Tsudo M, Fujimoto M, Hayashi K, Ohno H, Konaka Y, Katsurada T, Arima N, Doi S, Moriguchi T, Fukuhara S.
    Rinsho Ketsueki; 2001 Mar; 42(3):191-8. PubMed ID: 11345781
    [Abstract] [Full Text] [Related]

  • 4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 5. [Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
    Motomura S, Hashimoto C, Kodama F, Maruta A, Sakai R, Fujita H, Tomita N, Fujisawa S, Harano H, Koharazawa H, Fujimaki K, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 May; 46(5):350-7. PubMed ID: 16444968
    [Abstract] [Full Text] [Related]

  • 6. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
    Miyazaki K, Masuya M, Yamaguchi M, Isaka S, Nakase K, Kobayashi T, Nakamura S, Shiku H.
    Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
    [Abstract] [Full Text] [Related]

  • 7. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of non-Hodgkin's lymphoma].
    Yamane T, Hino M, Ohta K, Koh KR, Nakamae H, Aoyama Y, Ota T, Kishida T, Mugitani A, Sannomiya Y, Kamitani T, Takubo T, Tatsumi N.
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1547-55. PubMed ID: 11016000
    [Abstract] [Full Text] [Related]

  • 8. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, Forman SJ.
    Cancer; 2000 Aug 01; 89(3):680-9. PubMed ID: 10931469
    [Abstract] [Full Text] [Related]

  • 9. Hemolytic uremic syndrome following autologous peripheral blood stem cell transplantation in a patient with malignant lymphoma.
    Ohno E, Ohtsuka E, Iwashita T, Uno N, Ogata M, Kikuchi H, Nasu M.
    Bone Marrow Transplant; 1997 May 01; 19(10):1045-7. PubMed ID: 9169652
    [Abstract] [Full Text] [Related]

  • 10. [Development of Hodgkin's disease four years after autologous peripheral blood stem cell transplantation for multiple myeloma].
    Fujii H, Iwai T, Ueda Y, Nakagawa H.
    Rinsho Ketsueki; 2000 Dec 01; 41(12):1267-72. PubMed ID: 11201152
    [Abstract] [Full Text] [Related]

  • 11. Changes in the T-helper cell 1/T-helper cell 2 balance of peripheral T-helper cells after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Mukai M, Bohgaki T, Kondo M, Notoya A, Kohno M.
    Ann Hematol; 2001 Dec 01; 80(12):715-21. PubMed ID: 11797111
    [Abstract] [Full Text] [Related]

  • 12. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas.
    Mabed M, Al-Kgodary T.
    Bone Marrow Transplant; 2006 Apr 01; 37(8):739-43. PubMed ID: 16501587
    [Abstract] [Full Text] [Related]

  • 13. Ulcerative colitis after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Koike K, Kohda K, Kuga T, Nakazawa O, Ando M, Takayanagi N, Matsunaga T, Sakamaki S, Niitsu Y.
    Bone Marrow Transplant; 2001 Sep 01; 28(6):619-21. PubMed ID: 11607778
    [Abstract] [Full Text] [Related]

  • 14. Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol.
    Jantunen E, Mahlamäki E, Nousiainen T.
    Bone Marrow Transplant; 2000 Oct 01; 26(7):737-41. PubMed ID: 11042654
    [Abstract] [Full Text] [Related]

  • 15. Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Kamezaki K, Fukuda T, Makino S, Harada M.
    Clin Lab Haematol; 2004 Aug 01; 26(4):291-3. PubMed ID: 15279667
    [Abstract] [Full Text] [Related]

  • 16. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
    Messina G, Quartarone E, Console G, Cuzzola M, Iacopino O, Martino M, Irrera G, Morabito F, Iacopino P.
    Haematologica; 2002 Jul 01; 87(7):ECR22. PubMed ID: 12091138
    [Abstract] [Full Text] [Related]

  • 17. Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma.
    Pavone V, Gaudio F, Guarini A, Perrone T, Zonno A, Curci P, Liso V.
    Bone Marrow Transplant; 2002 Feb 01; 29(4):285-90. PubMed ID: 11896424
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation.
    Sasaki M, Matsue K, Takeuchi M, Mitome M, Hirose Y.
    Int J Hematol; 2000 Jan 01; 71(1):75-8. PubMed ID: 10729998
    [Abstract] [Full Text] [Related]

  • 19. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin's lymphoma: A report from the Korean society of pediatric hematology-oncology.
    Won SC, Han JW, Kwon SY, Shin HY, Ahn HS, Hwang TJ, Yang WI, Lyu CJ.
    Ann Hematol; 2006 Nov 01; 85(11):787-94. PubMed ID: 16932891
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW.
    Biol Blood Marrow Transplant; 2006 Sep 01; 12(9):965-72. PubMed ID: 16920563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.